Fake CVE exploit repos pull frint and skytext packages to steal researcher credentials, with servers still live as of July 1.
A campaign active since last November has been targeting Python developers building Telegram bots with trojanized Pyrogram ...
Since the FDA began publishing its rejections of drug approval filings in July last year, companies have become more forthcoming about the details of agency decisions in their own disclosures, ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
The U.S. Food and Drug Administration (FDA) has unveiled a sweeping transparency initiative that will fundamentally change how innovative drug and biologic developers interface with the Agency and the ...
The U.S. Food and Drug Administration (FDA) is now releasing complete response letters (CRLs) for BLA and NDA products not yet approved – including CRLs associated with pending or withdrawn ...
The issues addressed in these letters are usually related to "safety and efficacy concerns, manufacturing deficiencies, and bioequivalence issues." HealthDay News — The US Food and Drug Administration ...
The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as replies to drug and biological product applications submitted to the agency ...
The success of Foresight — a generative artificial intelligence (AI) model trained on records from 57 million people in England’s National Health Service (NHS ...
This project is a web app that extracts drug names from prescription images using OCR and retrieves detailed drug information via the OpenFDA API, helping users understand their medications better. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results